PolyPeptide Group AG (PPGN)

Currency in CHF
24.75
-0.95(-3.70%)
Closed·
PPGN Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
PPGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
24.7525.70
52 wk Range
13.2235.80
Key Statistics
Bid/Ask
24.00 / 25.80
Prev. Close
25.7
Open
25.5
Day's Range
24.75-25.7
52 wk Range
13.22-35.8
Volume
39.84K
Average Volume (3m)
32.25K
1-Year Change
-12.23%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PPGN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.72
Upside
+12.00%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

PolyPeptide Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

PolyPeptide Group AG Company Profile

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Employees
1362

Compare PPGN to Peers and Sector

Metrics to compare
PPGN
Peers
Sector
Relationship
P/E Ratio
−45.2x1.8x−0.5x
PEG Ratio
−0.720.000.00
Price/Book
2.5x1.4x2.6x
Price / LTM Sales
2.6x2.7x3.2x
Upside (Analyst Target)
10.3%48.5%41.7%
Fair Value Upside
Unlock10.6%6.1%Unlock

Analyst Ratings

3 Buy
1 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.72
(+12.00% Upside)

Earnings

Latest Release
Mar 01, 2025
EPS / Forecast
-0.24 / --
Revenue / Forecast
201.75M / --
EPS Revisions
Last 90 days

PPGN Income Statement

People Also Watch

146.85
SRENH
-0.31%
8.29
DOCM
+5.21%
53.16
ABBN
-0.41%
76.72
LOGN
+0.26%

FAQ

What Stock Exchange Does PolyPeptide Group AG Trade On?

PolyPeptide Group AG is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for PolyPeptide Group AG?

The stock symbol for PolyPeptide Group AG is "PPGN."

What Is the PolyPeptide Group AG Market Cap?

As of today, PolyPeptide Group AG market cap is 816.66M.

What Is PolyPeptide Group AG's Earnings Per Share (TTM)?

The PolyPeptide Group AG EPS (TTM) is -0.59.

From a Technical Analysis Perspective, Is PPGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has PolyPeptide Group AG Stock Split?

PolyPeptide Group AG has split 0 times.

How Many Employees Does PolyPeptide Group AG Have?

PolyPeptide Group AG has 1362 employees.

What is the current trading status of PolyPeptide Group AG (PPGN)?

As of 26 Jul 2025, PolyPeptide Group AG (PPGN) is trading at a price of 24.75, with a previous close of 25.70. The stock has fluctuated within a day range of 24.75 to 25.70, while its 52-week range spans from 13.22 to 35.80.

What Is PolyPeptide Group AG (PPGN) Price Target According to Analysts?

The average 12-month price target for PolyPeptide Group AG is CHF27.71978535, with a high estimate of CHF37.80027998 and a low estimate of CHF18.44143724. 3 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +12.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.